Cas:33758-16-6 (2S)-decan-2-ol manufacturer & supplier

Chemical Name:(2S)-decan-2-ol

CAS.NO:33758-16-6

Synonyms:(2S)-decan-2-ol

Molecular Formula:C₁₀H₂₂O

Molecular Weight:158.28100

HS Code:2905199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:211ºC(lit.)

Density:0.826 g/cm3

Index of Refraction:n20/D 1.434(lit.)

PSA:20.23000

Exact Mass:158.16700

LogP:3.11780

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2S)-decan-2-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-decan-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-decan-2-ol Use and application,(2S)-decan-2-ol technical grade,usp/ep/jp grade.

Related News: It is delivered to hospitals and pharmacies until it reaches the patient. (2S)-decan-2-ol manufacturer Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. (2S)-decan-2-ol supplier This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. (2S)-decan-2-ol vendor DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. (2S)-decan-2-ol factory Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.